Skip to main content
SpringerLink
Log in

Pharmacokinetic drug interactions with antineoplastic agents

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Loadman PM, Bibby MC. Pharmacokinetic drug interactions with anti-cancer drugs. Clin Pharmacokinet 1994; 26: 486–500

    Article  PubMed  CAS  Google Scholar 

  2. Liliemark J, Peterson C. Pharmacokinetic optimisation of anticancer therapy. Clin Pharmacokinet 1991; 21: 213–31

    Article  PubMed  CAS  Google Scholar 

  3. Cytotoxic drug interactions. In: Stockley IH. Drug interactions: a source book of adverse interactions, their mechanisms, clinical importance and management. 3rd ed. Oxford: Blackwell Scientific Publications, 1994; 279, 462–97

  4. van Meerten E, Verweij J, Schellens JHM. Antineoplastic agents: drug interactions of clinical significance. Drug Saf 1995; 12(3): 168–82

    Article  PubMed  Google Scholar 

  5. Mayall B, Poggi G, Parkin JD. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal. Med J Aust 1991; 155: 480–4

    PubMed  CAS  Google Scholar 

  6. Johnson AG, Seidemann P, Day RO. NSAID-related adverse drug interactions with clinical relevance. Int J Clin Pharmacol Ther 1994; 10: 509–32

    Google Scholar 

  7. Harvey VJ, Slevin ML. Dilloway MR, et al. The influence of cimetidine on the pharmacokinetics of 5-fluorouracil. Br J Clin Pharmac 1984; 18: 421–30

    Article  CAS  Google Scholar 

  8. Saaki Y, et al. Simultaneous administration of CPT-11 and fluorouracil: alteration of the pharmacokinetics of CPT-11 and SN-38 in patients with advanced colorectal cancer. J Natl Cancer Inst 1994; 86: 1096–98

    Article  Google Scholar 

  9. Lum BL, Kaubisch S, Yahanda AM, et al. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 1992; 10: 1635–42

    PubMed  CAS  Google Scholar 

  10. Rabinowits M, Souhami L, Gil RA, et al. Increased pulmonary toxicity with bleomycin and cisplatin chemotherapy combinations. Am J Clin Oncol 1990; 13: 132–8

    Article  PubMed  CAS  Google Scholar 

  11. Goren MP, Wright PK, Pratt CB, et al. Potentiation of ifosfamide neurotoxicity, hematoxicity, and tubular nephrotoxicity by prior cis-diamminedichlorplatinum (II) therapy. Cancer Res 1987; 47: 1457–60

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharmacokinetic drug interactions with antineoplastic agents. Drugs Ther. Perspect 5, 12–14 (1995). https://doi.org/10.2165/00042310-199505090-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505090-00005

Keywords

Search

Navigation